Production (Stage)
Docebo Inc.
DCBO.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 222.82M | 216.93M | 209.17M | 200.24M | 190.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 222.82M | 216.93M | 209.17M | 200.24M | 190.78M |
| Cost of Revenue | 43.01M | 41.54M | 40.05M | 38.37M | 36.56M |
| Gross Profit | 179.82M | 175.40M | 169.12M | 161.87M | 154.23M |
| SG&A Expenses | 111.99M | 108.64M | 106.95M | 105.39M | 104.03M |
| Depreciation & Amortization | 3.36M | 3.38M | 3.07M | 3.25M | 3.25M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 204.82M | 197.03M | 191.15M | 187.19M | 182.21M |
| Operating Income | 18.01M | 19.90M | 18.02M | 13.06M | 8.57M |
| Income Before Tax | 21.30M | 23.71M | 18.63M | 18.34M | 8.01M |
| Income Tax Expenses | -1.74M | -3.02M | 584.00K | 1.20M | 1.25M |
| Earnings from Continuing Operations | 23.04 | 26.74 | 18.05 | 17.14 | 6.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.04M | 26.74M | 18.05M | 17.14M | 6.76M |
| EBIT | 18.01M | 19.90M | 18.02M | 13.06M | 8.57M |
| EBITDA | 19.32M | 21.71M | 20.19M | 15.90M | 12.00M |
| EPS Basic | 0.76 | 0.88 | 0.59 | 0.55 | 0.22 |
| Normalized Basic EPS | 0.46 | 0.51 | 0.38 | 0.37 | 0.21 |
| EPS Diluted | 0.74 | 0.86 | 0.57 | 0.53 | 0.21 |
| Normalized Diluted EPS | 0.45 | 0.50 | 0.37 | 0.36 | 0.21 |
| Average Basic Shares Outstanding | 121.05M | 121.11M | 122.79M | 125.04M | 127.85M |
| Average Diluted Shares Outstanding | 123.87M | 123.99M | 125.90M | 128.48M | 130.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |